LOUISVILLE, Colo., July 22, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagno

Shares of Biodesix, Inc. (NASDAQ: BDSX - Get Free Report) have received an average rating of "Modera

Roth Capital analyst Max Masucci initiates coverage on Biodesix (NASDAQ:BDSX) with a Buy rating a

Biodesix (BDSX) was a big mover last session on higher-than-average trading volume. The latest trend

Here is how Biodesix, Inc. (BDSX) and BillionToOne (BLLN) have performed compared to their sector so

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's ana

BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth

The mean of analysts' price targets for Biodesix (BDSX) points to a 104.3% upside in the stock. Whil

LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnos

Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals

The mean of analysts' price targets for Biodesix (BDSX) points to a 103.3% upside in the stock. Whil

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus E

Delivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in

LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagn

Biodesix (NASDAQ: BDSX - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both

Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Cult

Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitori

A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test's consistent cli

The mean of analysts' price targets for Biodesix (BDSX) points to an 86.5% upside in the stock. Whil

Here is how Biodesix, Inc. (BDSX) and Coherus Oncology (CHRS) have performed compared to their secto

Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  On Friday morning, 446 companies hit new 52-week lows.

  Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn

    On Monday, 147 stocks hit new 52-week lows.

  On Thursday, 112 stocks made new 52-week lows.

Gainers